| Heading: |
Drugs: Misuse |
| Question ID: |
1815986 |
| UIN: |
62274 |
| House: |
Commons |
| Date tabled: |
2025-06-24 |
| Asking Member ID: |
4799 |
| Asking Member display name: |
Charlotte Nichols
|
| Asking Member handle: |
charlotte2153
|
| Asking Member Twitter reference: |
@charlotte2153
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what information his Department holds on the impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) needle and syringe exchange services on rates of skin and soft tissue inf |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-08 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department does not collect information on the impact of diamorphine assisted therapy (DAT), safe consumption rooms and needle and exchange services on rates of soft skin tissue infections (SSTI). The Department is aware of the dangers of SSTI to peop... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |